Well that’s sort of my point. Why bother with clinical trials and the huge dollars spent conducting them if at the end of the day the product sells and can get to where it’s needed faster. This is registered in over 30 countries and has undoubtedly saved lives. The right call was made IMO. Clinical trials haven’t been needed to attain approvals and registration in many developed markets with similar regulatory bodies. Why should Australia be any different particularly after the UK issues now sorted?
Viraleze Update, page-32
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.90M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.7¢ | $22.92K | 232.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 236173 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 50800 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |